HSIC Quote, Financials, Valuation and Earnings

Intelligent Bio Solutions, Inc. has a net margin of 3.27% compared to Henry Schein, Inc.'s net margin of -269.38%. Henry Schein, Inc.'s return on equity of 8.47% beat Intelligent Bio Solutions, Inc.'s return on equity of -255.54%.

Henry Schein, Inc. has a consensus price target of $77.00, signalling upside risk potential of 4.99%. On the other hand Intelligent Bio Solutions, Inc. has an analysts' consensus of -- which suggests that it could grow by 1506.64%. Given that Intelligent Bio Solutions, Inc. has higher upside potential than Henry Schein, Inc., analysts believe Intelligent Bio Solutions, Inc. is more attractive than Henry Schein, Inc..

Henry Schein, Inc. has a beta of 0.887, which suggesting that the stock is 11.251% less volatile than S&P 500. In comparison Intelligent Bio Solutions, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Henry Schein, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Intelligent Bio Solutions, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Henry Schein, Inc. pays -- of its earnings as a dividend. Intelligent Bio Solutions, Inc. pays out -- of its earnings as a dividend.

Henry Schein, Inc. quarterly revenues are $3.3B, which are larger than Intelligent Bio Solutions, Inc. quarterly revenues of $1.1M. Henry Schein, Inc.'s net income of $109M is higher than Intelligent Bio Solutions, Inc.'s net income of -$3M. Notably, Henry Schein, Inc.'s price-to-earnings ratio is 23.17x while Intelligent Bio Solutions, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Henry Schein, Inc. is 0.70x versus 1.48x for Intelligent Bio Solutions, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Standard BioTools, Inc. has a net margin of 3.27% compared to Henry Schein, Inc.'s net margin of -162.05%. Henry Schein, Inc.'s return on equity of 8.47% beat Standard BioTools, Inc.'s return on equity of -24.44%.

Henry Schein, Inc. has a consensus price target of $77.00, signalling upside risk potential of 4.99%. On the other hand Standard BioTools, Inc. has an analysts' consensus of $1.65 which suggests that it could grow by 7.64%. Given that Standard BioTools, Inc. has higher upside potential than Henry Schein, Inc., analysts believe Standard BioTools, Inc. is more attractive than Henry Schein, Inc..

Henry Schein, Inc. has a beta of 0.887, which suggesting that the stock is 11.251% less volatile than S&P 500. In comparison Standard BioTools, Inc. has a beta of 1.236, suggesting its more volatile than the S&P 500 by 23.585%.

Henry Schein, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Standard BioTools, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Henry Schein, Inc. pays -- of its earnings as a dividend. Standard BioTools, Inc. pays out -- of its earnings as a dividend.

Henry Schein, Inc. quarterly revenues are $3.3B, which are larger than Standard BioTools, Inc. quarterly revenues of $19.6M. Henry Schein, Inc.'s net income of $109M is higher than Standard BioTools, Inc.'s net income of -$31.7M. Notably, Henry Schein, Inc.'s price-to-earnings ratio is 23.17x while Standard BioTools, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Henry Schein, Inc. is 0.70x versus 4.24x for Standard BioTools, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

LENSAR, Inc. has a net margin of 3.27% compared to Henry Schein, Inc.'s net margin of -25.94%. Henry Schein, Inc.'s return on equity of 8.47% beat LENSAR, Inc.'s return on equity of -1013.45%.

Henry Schein, Inc. has a consensus price target of $77.00, signalling upside risk potential of 4.99%. On the other hand LENSAR, Inc. has an analysts' consensus of $15.00 which suggests that it could grow by 31.7%. Given that LENSAR, Inc. has higher upside potential than Henry Schein, Inc., analysts believe LENSAR, Inc. is more attractive than Henry Schein, Inc..

Henry Schein, Inc. has a beta of 0.887, which suggesting that the stock is 11.251% less volatile than S&P 500. In comparison LENSAR, Inc. has a beta of 0.665, suggesting its less volatile than the S&P 500 by 33.53%.

Henry Schein, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. LENSAR, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Henry Schein, Inc. pays -- of its earnings as a dividend. LENSAR, Inc. pays out -- of its earnings as a dividend.

Henry Schein, Inc. quarterly revenues are $3.3B, which are larger than LENSAR, Inc. quarterly revenues of $14.3M. Henry Schein, Inc.'s net income of $109M is higher than LENSAR, Inc.'s net income of -$3.7M. Notably, Henry Schein, Inc.'s price-to-earnings ratio is 23.17x while LENSAR, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Henry Schein, Inc. is 0.70x versus 2.28x for LENSAR, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Movano, Inc. has a net margin of 3.27% compared to Henry Schein, Inc.'s net margin of -5036.25%. Henry Schein, Inc.'s return on equity of 8.47% beat Movano, Inc.'s return on equity of -410.28%.

Henry Schein, Inc. has a consensus price target of $77.00, signalling upside risk potential of 4.99%. On the other hand Movano, Inc. has an analysts' consensus of $30.00 which suggests that it could grow by 3286.01%. Given that Movano, Inc. has higher upside potential than Henry Schein, Inc., analysts believe Movano, Inc. is more attractive than Henry Schein, Inc..

Henry Schein, Inc. has a beta of 0.887, which suggesting that the stock is 11.251% less volatile than S&P 500. In comparison Movano, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

Henry Schein, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Movano, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Henry Schein, Inc. pays -- of its earnings as a dividend. Movano, Inc. pays out -- of its earnings as a dividend.

Henry Schein, Inc. quarterly revenues are $3.3B, which are larger than Movano, Inc. quarterly revenues of $80K. Henry Schein, Inc.'s net income of $109M is higher than Movano, Inc.'s net income of -$4M. Notably, Henry Schein, Inc.'s price-to-earnings ratio is 23.17x while Movano, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Henry Schein, Inc. is 0.70x versus 13.41x for Movano, Inc.. Usually stocks with elevated PS ratios are considered overvalued.